Ozempic, Mounjaro, and Everything In Between: Your No-Nonsense Guide to GLP-1 Costs in 2024
Unless you've been completely off the grid, you've heard about GLP-1 medications. Ozempic. Mounjaro. Wegovy. Zepbound. They're everywhere — in the news, on social media, in conversations at the gym and the dinner table. And for good reason: these drugs have shown genuinely impressive results for weight loss and blood sugar control.
But here's the part that doesn't make it into the highlight reels: these medications can cost over $1,000 a month without insurance. And even with insurance, coverage is all over the place.
So let's cut through the noise. Here's a real breakdown of what GLP-1 drugs cost, how to get help paying for them, and what the compounded drug conversation is actually about.
What Are GLP-1 Medications, Anyway?
GLP-1 stands for glucagon-like peptide-1 — a hormone that helps regulate blood sugar and appetite. GLP-1 receptor agonists mimic this hormone, which is why they were originally developed as diabetes treatments. The weight loss effects were, initially, a happy side effect.
The main players right now:
- Ozempic (semaglutide) — FDA-approved for type 2 diabetes
- Wegovy (semaglutide) — FDA-approved for chronic weight management
- Mounjaro (tirzepatide) — FDA-approved for type 2 diabetes
- Zepbound (tirzepatide) — FDA-approved for chronic weight management
- Rybelsus (semaglutide) — oral version, approved for type 2 diabetes
- Victoza / Saxenda (liraglutide) — older generation, still prescribed
The key thing to understand is that Ozempic and Wegovy contain the same active ingredient (semaglutide), just at different doses and for different approved uses. Same story with Mounjaro and Zepbound (tirzepatide). This matters a lot when we start talking about coverage.
The Real Price Tag: What You're Looking At Out of Pocket
Let's get into the numbers, because this is where things get uncomfortable.
| Medication | List Price (Monthly) | With Manufacturer Coupon | With GoodRx/Discount |
|---|---|---|---|
| Ozempic | ~$935 | As low as $25 (if eligible) | ~$850–$900 |
| Wegovy | ~$1,350 | As low as $0 (if eligible) | ~$1,200+ |
| Mounjaro | ~$1,070 | As low as $25 (if eligible) | ~$950–$1,000 |
| Zepbound | ~$1,060 | As low as $25 (if eligible) | ~$950–$1,000 |
Those manufacturer coupons sound amazing — and they can be — but there's a catch. They typically exclude anyone on Medicare, Medicaid, or other federal programs. And they often have income or insurance requirements. The fine print is worth reading very carefully.
Insurance Coverage: The Frustrating Reality
Here's where a lot of people get blindsided. Insurance coverage for GLP-1s is wildly inconsistent, and it often comes down to why you're taking the drug.
For diabetes: Most commercial insurance plans cover Ozempic and Mounjaro reasonably well, though prior authorization is almost always required. You'll need documented evidence that you have type 2 diabetes and that other medications haven't been sufficient.
For weight loss: This is where coverage falls apart. Many insurance plans — including most employer-sponsored plans — still don't cover Wegovy or Zepbound for obesity treatment. Medicare Part D was only recently permitted to cover weight-loss drugs at all, and that coverage is still rolling out.
What to do: Call your insurance company directly and ask whether your specific medication is on their formulary, what tier it's on, and what the prior authorization requirements are. Don't just assume it's covered — or that it isn't. The landscape is changing fast.
The Compounded Drug Option: What You Need to Know
Due to ongoing shortages of semaglutide and tirzepatide, the FDA allowed compounding pharmacies to produce their own versions of these medications. This opened a significant new market — and a significant amount of confusion.
What compounded GLP-1s are: Medications made by licensed compounding pharmacies that contain the same active ingredient as the brand-name drug, often at a much lower price. Some telehealth companies have built entire business models around prescribing and shipping compounded semaglutide or tirzepatide.
What they cost: Compounded semaglutide through telehealth platforms has been advertised anywhere from $150 to $400 per month — a dramatic difference from brand-name pricing.
The important caveats:
- Compounded drugs are not FDA-approved. They're legal under specific shortage conditions, but they don't go through the same approval process as brand-name drugs.
- Quality can vary between compounding pharmacies. Look for pharmacies accredited by PCAB (Pharmacy Compounding Accreditation Board).
- The FDA has raised concerns about some compounded versions, particularly those using salt forms of semaglutide rather than the base compound. Ask your prescriber specifically about this.
- As the shortage status changes, the legal availability of compounded GLP-1s may shift. Stay updated.
Bottom line on compounding: It can be a legitimate, more affordable option for some people — but it requires doing your homework and working with a reputable provider.
Assistance Programs Worth Knowing About
If you're struggling with GLP-1 costs, here are real programs to explore:
Novo Nordisk Patient Assistance Program — For Ozempic and Wegovy. Income-based eligibility. Uninsured or underinsured patients may qualify for free medication.
Eli Lilly's Insulin Value Program / LillyAnswers — For Mounjaro and Zepbound. Similar structure, worth a call to see if you qualify.
NeedyMeds.org — A nonprofit database of patient assistance programs across hundreds of drugs. Free to search.
State Pharmaceutical Assistance Programs (SPAPs) — Several states have their own programs that supplement Medicare coverage. Check your state's Department of Health or Aging.
Telehealth platforms with bundled pricing — Some services bundle the prescription, provider visit, and compounded medication into a monthly fee. Compare these carefully — sometimes the total cost is lower than you'd expect.
Smart Questions to Ask Your Doctor
Before you leave your next appointment, ask:
- "Which of these drugs are you prescribing for — diabetes or weight management?" The diagnosis on the prescription affects what insurance will cover.
- "Is there a clinical reason I need the brand-name version, or would a compounded alternative be medically appropriate for me?"
- "Can you help me with a prior authorization for insurance coverage?" Many physicians have staff who handle this — but they often need you to ask.
- "What happens to my health if I have to stop due to cost?" Understanding the risk of discontinuing helps you prioritize.
The Takeaway
GLP-1 medications represent a genuine breakthrough in metabolic health — but the pricing structure around them is genuinely broken for a lot of Americans. The gap between what these drugs cost and what people can actually afford is real, and it's leading people to make decisions without full information.
At Cost of Via, our job is to make sure you have the actual numbers in front of you before you make any decision. Whether you're considering brand-name, compounded, or exploring assistance programs, knowing the real cost is always step one.
